Sort
326,823 grants matching “clinical trial”
SPORE in Prostate Cancer
$2,126,680William J Catalona · Northwestern University At Chicago · P50 · FY2019 · CA
SPORE in Prostate Cancer
$2,126,579Yu Chen · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Alzheimer's Disease Risk Genes in Human Microglia and Neurons Derived from iPSCs
$2,126,485Li-Huei Tsai · Massachusetts Institute Of Technology · RF1 · FY2014 · AG
SPORE in Soft Tissue Sarcoma
$2,126,450Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
SPORE in Soft Tissue Sarcoma
$2,126,450Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
SPORE in Soft Tissue Sarcoma
$2,126,449Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
Human Retinal Imaging Biomarkers for FTLD-Tau in Relation to FTLD-TDP and Nonamnestic AD
$2,126,420Benjamin J. Kim · University Of Pennsylvania · RF1 · FY2023 · AG
Extracellular RNA biomarkers of myotonic dystrophy type 1
$2,126,281Thurman M Wheeler · Massachusetts General Hospital · R61 · FY2021 · NS
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2020 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2021 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2019 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2018 · HD
Gastroparesis Consortium Continuation-Data Coordinating Center
$2,126,196James A Tonascia · Johns Hopkins University · U01 · FY2012 · DK
Center for Native Oral Health Research (CNOHR)
$2,126,118Judith E.n. Albino · University Of Colorado Denver · U54 · FY2009 · DE
Community Clinical Oncology program Research Base
$2,126,089Brad H. Pollock · National Childhood Cancer Foundation · U10 · FY2009 · CA
Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms
$2,125,950Derya Unutmaz · Jackson Laboratory · U54 · FY2017 · NS
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure
$2,125,769Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · HL
ADMINISTRATIVE CORE
$2,125,707Paul S. Aisen · University Of California, San Diego · U19 · FY2013 · AG
Targeting Lung Cancer Vulnerabilities
$2,125,682John D Minna · Ut Southwestern Medical Center · P50 · FY2021 · CA
Research Expanding Access to Child Health (REACH)
$2,125,615Anne E Kazak · Nemours Children'S Hospital, Delaware · P20 · FY2023 · GM
PROTON RADIATION THERAPY RESEARCH
$2,125,543Massachusetts General Hospital · P01 · FY2000 · CA
Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men
$2,125,498Ronald G Victor · Cedars-Sinai Medical Center · R01 · FY2016 · HL
Hepatitis B Clinical Research Network - Data Coordinating Center
$2,125,406Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · DK
Alabama Clinical Trials Unit
$2,125,363Edgar T Overton · University Of Alabama At Birmingham · UM1 · FY2020 · AI
ASIAN AMERICAN NETWORK FOR CANCER AWAREN, RESEARCH &TRG
$2,125,292University Of California Davis · U01 · FY2003 · CA